Our studies showed that significant differences in MN activity and survival between ALS (C9orf72-mutated) and isogenic preparations could be detected as early as 4-weeks post-plating using phMNENRICHED cultures. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.